Author ORCID Identifier
Dylan Thibaut - 0000-0002-8739-9688
Ryan Witcher - 0000-0001-5234-3636
Anitha Kunnath - 0000-0003-2385-2102
James Toldi - 0000-0002-5304-4555
Abstract
Abstract
Introduction: Pigeon Breeder’s Pneumonitis (PBP) results due to a complex pathophysiology that includes exposure to avian antigens. Susceptibility has been linked to human leukocyte antigen (HLA) class II, though consensus has not been reached. The goal of this systematic review is to further elucidate the association between PBP and HLA-DR subtypes.
Methods: Databases utilized included PubMed, Google Scholar, ScienceDirect, and Cochrane Library. Inclusion required a minimum of three studies in English presenting HLA-DR alleles of PBP and control subgroups. Exclusion was due to insufficient data or non-feasible control groups. Forest plots were created for HLA-DR subtypes’ association with PBP. The NIH Bias assessment tool and LFK index assessed bias.
Results: 4 studies were included in the meta-analysis. HLA-DR3 was associated with the pooled PBP subgroups (OR=1.86 [1.13, 3.05], p
Discussion: Limitations included limited sources, with multiple study methodology unacceptable to this review. These findings expand on previous research on HLA variants and PBP frequency, and offer further clarity supporting novel approaches in treatment of PBP.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Recommended Citation
Thibaut D, Witcher RA, Kunnath A, Toldi J. Extrinsic Allergic Alveolitis: A Systematic Review of HLA-DR in Pigeon Breeder’s Disease. Advances in Clinical Medical Research and Healthcare Delivery. 2023; 3(2). doi: 10.53785/2769-2779.1150.
Publisher Note
All articles published in ACMRHD are distributed with a Creative Commons CC BY-NC 4.0 license. Under this license, authors hold the copyright to their work and have the right to share or adapt the article with no restrictions, as long as the author(s) and source are cited, and the use is for noncommercial purposes. This policy went into effect November 1, 2023, and applies retroactively to all articles published in ACMRHD prior to that date, as well.
Included in
Allergy and Immunology Commons, Animal Diseases Commons, Disorders of Environmental Origin Commons, Epidemiology Commons, Family Medicine Commons, Genetic Phenomena Commons, Immune System Diseases Commons, Medical Genetics Commons, Pulmonology Commons, Respiratory Tract Diseases Commons, Rheumatology Commons